SJS Investment Consulting’s Lifecore Biomedical LFCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$857 Buy
130
+2
+2% +$9 ﹤0.01% 2575
2026
Q2
$672 Hold
128
– – ﹤0.01% 2165
2026
Q1
$477 Sell
128
-46
-26% -$318 ﹤0.01% 1758
2025
Q4
$1.42K Hold
174
– – ﹤0.01% 1203
2025
Q3
$1.28K Hold
174
– – ﹤0.01% 934
2025
Q2
$1.41K Hold
174
– – ﹤0.01% 693
2025
Q1
$1.22K Buy
+174
New +$1.08K ﹤0.01% 932

Other funds holding LFCR

SJS Investment Consulting's LFCR Position: Q3 2026 in Review

SJS Investment Consulting increased its Lifecore Biomedical (LFCR) stake by 1.6% in Q3 2026, buying an estimated $9 and bringing the position to 130 shares worth $857. The position accounts for ﹤0.01% of the portfolio, ranked #2575.

SJS Investment Consulting first reported a position in LFCR in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.42K in Q4 2025. 105 funds tracked by Wall St. Rank hold LFCR as of Q3 2026.

  • SJS Investment Consulting held 130 shares of Lifecore Biomedical worth $857 as of Q3 2026.
  • SJS Investment Consulting bought 2 Lifecore Biomedical shares in Q3 2026, an estimated $9.
  • Lifecore Biomedical made up ﹤0.01% of SJS Investment Consulting's portfolio in Q3 2026, its #2575 holding.
  • SJS Investment Consulting first reported a position in Lifecore Biomedical in Q1 2025 and has held it in 7 quarters since.
  • SJS Investment Consulting's Lifecore Biomedical position peaked at $1.42K in Q4 2025.
  • 105 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2026.

Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.